- Home
- BSII vs ARAY Comparison
BSII vs ARAY Comparison
Compare BSII & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSII
- ARAY
- Stock Information
- Founded
- BSII 2024
- ARAY 1990
- Country
- BSII Hong Kong
- ARAY United States
- Employees
- BSII N/A
- ARAY N/A
- Industry
- BSII
- ARAY Medical/Dental Instruments
- Sector
- BSII
- ARAY Health Care
- Exchange
- BSII Nasdaq
- ARAY Nasdaq
- Market Cap
- BSII 189.9M
- ARAY 180.0M
- IPO Year
- BSII 2024
- ARAY 2007
- Fundamental
- Price
- BSII $9.95
- ARAY $2.24
- Analyst Decision
- BSII
- ARAY Strong Buy
- Analyst Count
- BSII 0
- ARAY 1
- Target Price
- BSII N/A
- ARAY $9.00
- AVG Volume (30 Days)
- BSII 296.0
- ARAY 664.5K
- Earning Date
- BSII 01-01-0001
- ARAY 01-29-2025
- Dividend Yield
- BSII N/A
- ARAY N/A
- EPS Growth
- BSII N/A
- ARAY N/A
- EPS
- BSII N/A
- ARAY N/A
- Revenue
- BSII N/A
- ARAY $444,204,000.00
- Revenue This Year
- BSII N/A
- ARAY $6.64
- Revenue Next Year
- BSII N/A
- ARAY $5.69
- P/E Ratio
- BSII N/A
- ARAY N/A
- Revenue Growth
- BSII N/A
- ARAY N/A
- 52 Week Low
- BSII $10.05
- ARAY $1.40
- 52 Week High
- BSII $10.30
- ARAY $2.99
- Technical
- Relative Strength Index (RSI)
- BSII N/A
- ARAY 60.03
- Support Level
- BSII N/A
- ARAY $2.04
- Resistance Level
- BSII N/A
- ARAY $2.34
- Average True Range (ATR)
- BSII 0.00
- ARAY 0.15
- MACD
- BSII 0.00
- ARAY 0.03
- Stochastic Oscillator
- BSII 0.00
- ARAY 82.76
About BSII Black Spade Acquisition II Co Class A Ordinary Share
Black Spade Acquisition II Co is a blank check company.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.